DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Unnithan JS, Choueiri T, Garcia J, Dreicer R, Laura W, Bukowski R, Rini B.
Safety of VEGF-targeted tyrosine kinase inhibitors in
patients (Pts) with metastatic renal cell carcinoma (mRCC) and central nervous
system (CNS) metastases.
J Clin Oncol 2007; 25
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.